Abstract
Tumor tissue oxygenation significantly affects the outcome of radiotherapy. Real-time monitoring of tumor hypoxia is highly desirable for effective radiotherapy, and is the basis for improved treatment because hypoxic tumor cells are more resistant to radiation damage than fully oxygenated cells. We propose to use Cerenkov imaging to monitor tumor hypoxia by means of tissue blood oxygenation without the need for any exogenous contrast agent. Using a rodent hypoxia model, we demonstrate that Cerenkov imaging can be used as a noninvasive and noncontact method to measure tissue blood oxygenation level during radiation delivery. The data from Cerenkov imaging were validated using near infrared spectrometry methods. The results demonstrate the feasibility of using Cerenkov imaging to monitor tumor hypoxia during therapeutic radiation delivery.
© 2017 Optical Society of America
Full Article | PDF ArticleMore Like This
Lixin Dong, Mahesh Kudrimoti, Ran Cheng, Yu Shang, Ellis L. Johnson, Scott D. Stevens, Brent J. Shelton, and Guoqiang Yu
Biomed. Opt. Express 3(2) 259-272 (2012)
Maomao Chen, Hailey J. Knox, Yuqi Tang, Wei Liu, Liming Nie, Jefferson Chan, and Junjie Yao
Opt. Lett. 44(15) 3773-3776 (2019)
Rongxiao Zhang, Adam Glaser, Tatiana V. Esipova, Stephen C. Kanick, Scott C. Davis, Sergei Vinogradov, David Gladstone, and Brian W. Pogue
Biomed. Opt. Express 3(10) 2381-2394 (2012)